SARS-CoV-2 ORF6 disrupts innate immune signalling by inhibiting cellular mRNA export. (2022)
Attributed to:
G2P-UK; A National Virology Consortium to address phenotypic consequences of SARSCoV-2 genomic variation
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1371/journal.ppat.1010349
PubMed Identifier: 36007063
Publication URI: http://europepmc.org/abstract/MED/36007063
Type: Journal Article/Review
Volume: 18
Parent Publication: PLoS pathogens
Issue: 8
ISSN: 1553-7366